Brigit Biofarmaka Teknologi Tbk. vs Tower Bersama Infrastructure Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Tower Bersama Infrastructure Tbk. trades at Rp1,415 (market cap 32.29T, 524K 24h volume). The key difference: Tower Bersama Infrastructure Tbk. is far larger — about 186.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 524K). Which is the better fit depends on your goals.
| OBAT | TBIG | |
|---|---|---|
Market Cap | 172.82B | 32.29T |
Volume | 592.2K | 524K |
Lot | 5.92K | 5.24K |
Turnover | 147.05M | 742.96M |
Average Price | 248.31 | 1,417.86 |
Value | 147.05M | 742.96M |
Indicative Equilibrium Price | 254 | 1,415 |
Indicative Equilibrium Volume | 10 | 664 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Tower Bersama Infrastructure (the Company) was established under its original name of PT Banyan Mas on Nov 8th, 2004 then changed to PT Tower Bersama Infrastructure based on Notaries Deed dated Oct 24, 2009 and the deed of establishment was approved by the the Ministry of Justice dated Feb 13, 2008. The Company’s articles of association has been amended several times, most recently by notarial deed No. 145 of Aulia Taufani, S.H., dated Jul 21, 2010, concerning among others, the change in the Company’s name, equity, public company and for the amendments in the company's whole articles of Association to comply with the requirements of the Capital Market and Financial Institutions Supervisory Agency.
Read more on TBIG →